ÂÜÀòÂÒÂ×

Shannon Foley is a finance professional with extensive experience in various leadership roles across the pharmaceutical and healthcare industries. Currently serving as VP Head of Finance at Adiso Therapeutics since January 2022, Shannon previously held similar positions at Morningside BioPharma Advisory and Ameresco, progressing from Senior Director to Sr Director of Accounting. Earlier career stages included significant roles at ZOLL Medical Corporation and GT Advanced Technologies, where responsibilities included overseeing global accounting and financial systems. Shannon's foundation in accounting was established at PricewaterhouseCoopers, focusing on the Pharmaceutical, Medical Device, and Healthcare sectors. Shannon holds a Bachelor of Science in Accounting from the University of Rhode Island.